Neuropeptide Y Neurons in Feeding Behavior

Neuropeptide Y Neurons in Feeding Behavior

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Neuropeptide Y Neurons in Feeding Behavior</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Metabolism / Neuroendocrinology</td>
</tr>
<tr>
<td class="label">Primary Location</td>
<td>Arcuate Nucleus (Arc) of Hypothalamus</td>
</tr>
<tr>
<td class="label">Additional Regions</td>
<td>Paraventricular Nucleus (PVN), Lateral Hypothalamus, Dorsomedial Hypothalamus</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Orexigenic peptidergic neurons</td>
</tr>
<tr>
<td class="label">Neuropeptide</td>
<td>Neuropeptide Y (NPY)</td>
</tr>
<tr>
<td class="label">Co-transmitters</td>
<td>Agouti-related peptide (AgRP)</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>Y1, Y2, Y4, Y5 (GPCR family)</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Appetite stimulation, energy storage, stress response modulation</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Function</td>
</tr>
<tr>
<td class="label">NPY/AgRP neurons</td>
<td>Orexigenic (appetite stimulate)</td>
</tr>
<tr>
<td class="label">POMC neurons</td>
<td>Anorexi

...

Neuropeptide Y Neurons in Feeding Behavior

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Neuropeptide Y Neurons in Feeding Behavior</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Metabolism / Neuroendocrinology</td>
</tr>
<tr>
<td class="label">Primary Location</td>
<td>Arcuate Nucleus (Arc) of Hypothalamus</td>
</tr>
<tr>
<td class="label">Additional Regions</td>
<td>Paraventricular Nucleus (PVN), Lateral Hypothalamus, Dorsomedial Hypothalamus</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Orexigenic peptidergic neurons</td>
</tr>
<tr>
<td class="label">Neuropeptide</td>
<td>Neuropeptide Y (NPY)</td>
</tr>
<tr>
<td class="label">Co-transmitters</td>
<td>Agouti-related peptide (AgRP)</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>Y1, Y2, Y4, Y5 (GPCR family)</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Appetite stimulation, energy storage, stress response modulation</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Function</td>
</tr>
<tr>
<td class="label">NPY/AgRP neurons</td>
<td>Orexigenic (appetite stimulate)</td>
</tr>
<tr>
<td class="label">POMC neurons</td>
<td>Anorexigenic (appetite suppress)</td>
</tr>
<tr>
<td class="label">Target Region</td>
<td>Projection Type</td>
</tr>
<tr>
<td class="label">Paraventricular Nucleus</td>
<td>Inhibitory (NPY)</td>
</tr>
<tr>
<td class="label">Lateral Hypothalamus</td>
<td>Disinhibitory</td>
</tr>
<tr>
<td class="label">Dorsomedial Hypothalamus</td>
<td>Inhibitory</td>
</tr>
<tr>
<td class="label">Preoptic Area</td>
<td>Inhibitory</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Autonomic projections</td>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Distribution</td>
</tr>
<tr>
<td class="label">Y1</td>
<td>Hypothalamus, cortex, amygdala</td>
</tr>
<tr>
<td class="label">Y2</td>
<td>Hypothalamus (presynaptic)</td>
</tr>
<tr>
<td class="label">Y4</td>
<td>Brainstem, colon</td>
</tr>
<tr>
<td class="label">Y5</td>
<td>Hypothalamus</td>
</tr>
<tr>
<td class="label">Resting membrane potential</td>
<td>-45 to -55 mV</td>
</tr>
<tr>
<td class="label">Action potential duration</td>
<td>1.5-3 ms</td>
</tr>
<tr>
<td class="label">Firing pattern</td>
<td>Low baseline, burst during fasting</td>
</tr>
<tr>
<td class="label">Input resistance</td>
<td>~300-500 MΩ</td>
</tr>
<tr>
<td class="label">Synaptic plasticity</td>
<td>Long-term potentiation at excitatory synapses</td>
</tr>
<tr>
<td class="label">NPY Alteration</td>
<td>Effect in AD</td>
</tr>
<tr>
<td class="label">Reduced hippocampal NPY</td>
<td>Impaired memory consolidation</td>
</tr>
<tr>
<td class="label">Elevated hypothalamic NPY</td>
<td>Metabolic dysfunction, weight loss</td>
</tr>
<tr>
<td class="label">NPY-Y1 signaling</td>
<td>Neuroprotective effects in cortex</td>
</tr>
<tr>
<td class="label">Metabolic Factor</td>
<td>NPY Relationship</td>
</tr>
<tr>
<td class="label">Obesity</td>
<td>Elevated NPY</td>
</tr>
<tr>
<td class="label">Type 2 Diabetes</td>
<td>NPY resistance</td>
</tr>
<tr>
<td class="label">Insulin resistance</td>
<td>Altered NPY signaling</td>
</tr>
<tr>
<td class="label">High cortisol</td>
<td>NPY dysregulation</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">Y1 receptor</td>
<td>Antagonists for obesity</td>
</tr>
<tr>
<td class="label">Y2 receptor</td>
<td>Agonists for satiety</td>
</tr>
<tr>
<td class="label">Y5 receptor</td>
<td>Antagonists for feeding</td>
</tr>
<tr>
<td class="label">NPY analog</td>
<td>Pan-receptor agonists</td>
</tr>
</table>

Introduction

Neuropeptide Y Neurons In Feeding Behavior is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Neuropeptide Y (NPY) neurons are orexigenic (appetite-stimulating) neurons primarily located in the hypothalamus that play a critical role in energy homeostasis, stress responses, and neurodegeneration. These neurons are central to understanding metabolic aspects of Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). [@pedrazzini2003]

Overview

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: immature neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

External Database Links

• [Cell Ontology (CL:4042028)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)
• [OBO Foundry (CL:4042028)](http://purl.obolibrary.org/obo/CL_4042028)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Neuroanatomy

Arcuate Nucleus Location

The arcuate nucleus (Arc) of the hypothalamus contains two key neuronal populations:

The NPY/AgRP neurons are located in the medial portion of the Arc, adjacent to the median eminence, which allows them to sense circulating hormones and nutrients.

Hypothalamic Circuitry

Afferent Inputs

NPY neurons receive inputs from:

Leptin-sensitive circuits: From POMC neurons (inverse regulation)

Insulin-sensitive neurons: Energy store signaling

Circadian rhythm neurons: Suprachiasmatic nucleus inputs

Stress-responsive neurons: CRF and norepinephrine inputs

Mesolimbic dopamine system: Reward-related feeding

Molecular Mechanisms

NPY Receptor Signaling

Receptor Pharmacology

Downstream Effects

NPY binding to its receptors causes:

• Inhibition of adenylate cyclase: Reduced cAMP signaling
• Activation of N-type calcium channels: Enhanced neurotransmission
• MAPK activation: Long-term growth and plasticity changes
• ERK1/2 phosphorylation: Gene expression changes

Electrophysiology

NPY/AgRP neurons have distinctive electrophysiological properties:

Fasting Response

During fasting:

Ghrelin (from stomach) activates NPY neurons

Leptin (from fat) decreases, removing inhibition

NPY neuron firing rate increases dramatically

Feeding behavior is stimulated

Role in Neurodegeneration

Alzheimer's Disease

NPY is significantly altered in AD and may influence disease progression:

Amyloid-β effects: Aβ reduces NPY expression in hippocampus

Learning and memory: NPY modulates hippocampal synaptic plasticity

Stress response: NPY counteracts CRF effects; imbalance may worsen outcomes

Metabolic dysfunction: NPY dysregulation contributes to AD-related metabolic issues

Parkinson's Disease

NPY neurons are affected in PD through several mechanisms:

α-Synuclein pathology: NPY neurons may be vulnerable to aggregation

Dopamine-NPY interaction: Nigrostriatal dopamine loss affects NPY regulation

Weight loss: PD-associated cachexia involves NPY dysregulation

Non-motor symptoms: NPY alterations contribute to depression and anxiety

Amyotrophic Lateral Sclerosis

NPY system alterations in ALS:

• Motor neuron excitability modulation
• Energy homeostasis disruption
• Stress response amplification
• Possible therapeutic target

Metabolic Syndrome Connection

Metabolic syndrome is a risk factor for neurodegeneration:

Clinical Significance

Therapeutic Implications

NPY in Neurodegenerative Disease Treatment

Y1 receptor agonists: Potential neuroprotective effects

Y2 receptor modulation: Anti-stress effects

Lifestyle interventions: Diet, exercise to normalize NPY

Combination therapy: NPY modulation + disease-modifying treatments

See Also

• [Neuropeptide Y - The peptide ligand
• Arcuate Nucleus Neurons - Energy homeostasis
• AgRP Neurons - Co-localized orexigenic neurons
• POMC Neurons - Opposing anorexigenic population
• Hypothalamic Orexin Neurons - Wakefulness and feeding
• [Alzheimer's Disease](/diseases/al- [Parkinson's Disease](/diseases/parkinsons-disease)erview
• [Parkinson's Disease](/diseases/parkinsons-disease) PD overview
• Metabolic Syndrome - Metabolic risk factors

](/cell-types/neuropeptide-y---the-peptide-ligand
--arcuate-nucleus-neurons---energy-homeostasis
--agrp-neurons---co-localized-orexigenic-neurons
--pomc-neurons---opposing-anorexigenic-population
--hypothalamic-orexin-neurons---wakefulness-and-feeding
--alzheimer's-disease---ad-overview
--parkinson's-disease---pd-overview
--metabolic-syndrome---metabolic-risk-factors)## Background

The study of Neuropeptide Y Neurons In Feeding Behavior has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data